TY - JOUR
T1 - ACC/AHA and ESC/EACTS Guidelines for the Management of Valvular Heart Diseases: JACC Guideline Comparison
AU - Coisne, Augustin
AU - Lancellotti, Patrizio
AU - Habib, Gilbert
AU - Garbi, Madalina
AU - Dahl, Jordi Sanchez
AU - Barbanti, Marco
AU - Vannan, Mani A.
AU - Vassiliou, Vassilios S.
AU - Dudek, Dariusz
AU - Chioncel, Ovidiu
AU - Waltenberger, Johannes L.
AU - Johnson, Victoria L.
AU - De Paulis, Ruggero
AU - Citro, Rodolfo
AU - Pibarot, Philippe
AU - EuroValve Consortium
N1 - Publisher Copyright:
© 2023 American College of Cardiology Foundation
PY - 2023/8/22
Y1 - 2023/8/22
N2 - Valvular heart disease (VHD) is common and poses important challenges from the standpoints of diagnosis and therapeutic management. Clinical practice guidelines have been developed to help health care professionals to overcome these challenges and provide optimal management to patients with VHD. The American College of Cardiology, in collaboration with the American Heart Association, and the European Society of Cardiology, in collaboration with the European Association for Cardio-Thoracic Surgery, recently updated their guidelines on the management of VHD. Although these 2 sets of guidelines are generally concordant, there are some substantial differences between these guidelines, which may have significant implications for clinical practice. This review prepared on behalf of the EuroValve Consortium describes the consistencies and discrepancies between the guidelines and highlights the gaps in these guidelines and the future research perspectives to fill these gaps.
AB - Valvular heart disease (VHD) is common and poses important challenges from the standpoints of diagnosis and therapeutic management. Clinical practice guidelines have been developed to help health care professionals to overcome these challenges and provide optimal management to patients with VHD. The American College of Cardiology, in collaboration with the American Heart Association, and the European Society of Cardiology, in collaboration with the European Association for Cardio-Thoracic Surgery, recently updated their guidelines on the management of VHD. Although these 2 sets of guidelines are generally concordant, there are some substantial differences between these guidelines, which may have significant implications for clinical practice. This review prepared on behalf of the EuroValve Consortium describes the consistencies and discrepancies between the guidelines and highlights the gaps in these guidelines and the future research perspectives to fill these gaps.
KW - comparison
KW - guidelines
KW - valvular heart disease
UR - http://www.scopus.com/inward/record.url?scp=85166917395&partnerID=8YFLogxK
U2 - 10.1016/j.jacc.2023.05.061
DO - 10.1016/j.jacc.2023.05.061
M3 - Review article
C2 - 37587584
AN - SCOPUS:85166917395
VL - 82
SP - 721
EP - 734
JO - Journal of the American College of Cardiology
JF - Journal of the American College of Cardiology
SN - 0735-1097
IS - 8
ER -